Weight Loss Peptides
9 research peptides in this category.
Retatrutide
Retatrutide (LY3437943)
Triple Agonist Peptide for Weight Loss
- MW
- 4731 g/mol
- CAS
- 2381089-83-2
- Route
- Subcutaneous injection, once weekly
Semaglutide
Semaglutide (GLP-1 Receptor Agonist)
GLP-1 Peptide for Weight Loss
- MW
- 4114 g/mol (average; FDA label states 4113.58 g/mol)
- CAS
- 910463-68-2
- Route
- Subcutaneous injection, once weekly (also available orally as Rybelsus)
Tirzepatide
Tirzepatide (Dual GIP/GLP-1 Receptor Agonist)
Dual Agonist Peptide for Weight Loss
- MW
- 4813.5 g/mol
- CAS
- 2023788-19-2
- Route
- Subcutaneous injection, once weekly
AOD-9604
AOD-9604 (hGH Fragment 176-191)
Modified Growth Hormone Fragment for Fat Loss
- MW
- 1815.1 g/mol
- CAS
- 221231-10-3
- Route
- Subcutaneous injection in current practice/research use; original Metabolic Pharmaceuticals human clinical trials used intravenous infusion (METAOD001-002) and oral capsules/tablets (METAOD003-006)
Liraglutide
Liraglutide (Saxenda / Victoza)
GLP-1 Receptor Agonist for Weight Loss
- MW
- 3751.26 g/mol
- CAS
- 204656-20-2
- Route
- Subcutaneous injection, once daily
Adipotide
Adipotide (FTPP -- Fat-Targeted Proapoptotic Peptide)
Vascular-Targeting Peptide for Fat-Specific Weight Loss
- MW
- 2557.2 g/mol
- CAS
- 859216-15-2
- Route
- Subcutaneous injection
Cagrilintide
Cagrilintide (Long-Acting Amylin Analog)
Long-Acting Amylin Analog for Weight Loss
- MW
- 4409 g/mol
- CAS
- 1415456-99-3
- Route
- Subcutaneous injection, once weekly
Dulaglutide
Long-Acting GLP-1 Receptor Agonist for Weight Loss
- MW
- ~63 kDa (approx. 63,000 g/mol)
- CAS
- 923950-08-7
- Route
- Subcutaneous injection, once weekly
hGH Fragment 176-191
C-Terminal GH Fragment for Targeted Fat Loss
- MW
- 1859.1 g/mol (PubChem CID 172966176, acetate salt form)
- CAS
- 66004-57-7